Continued Rapid Increase in Thyroid Cancer Incidence in California: Trends by Patient, Tumor, and Neighborhood Characteristics
A partir des données du registre californien des cancers portant sur 46 087 cas, cette étude analyse l'évolution du cancer de la thyroïde sur la période 1988-2009, en fonction des caractéristiques du patient, de la tumeur et de facteurs ethniques et socioéconomiques
Résumé en anglais
Background: Thyroid cancer incidence is increasing worldwide. Incorporating 22 years of incidence data through 2009, we extend examination of these trends among a wide array of subgroups defined by patient (age, sex, race/ethnicity, and nativity), tumor (tumor size and stage), and neighborhood (socioeconomic status and residence in ethnic enclaves) characteristics, to identify possible reasons for this increase.
Methods: Thyroid cancer incidence data on 10,940 men and 35,147 women were obtained from the California Cancer Registry for 1988–2009. Population data were obtained from the 1990 and 2000 U.S. Census. Incidence rates and 95% confidence intervals (CI) were calculated and incidence trends were evaluated using Joinpoint regression to evaluate the timing and magnitude of change [annual percentage change (APC) and rate ratios].
Results: The incidence of papillary thyroid cancer continues to increase in both men (APC, 5.4; 95% CI, 4.5–6.3 for 1998–2009) and women (APC, 3.8; 95% CI, 3.4–4.2 for 1998–2001 and APC, 6.3; 95% CI, 5.7–6.9 for 2001–2009). Increasing incidence was observed in all subgroups examined.
Conclusions: Although some variation in the magnitude or temporality of the increase in thyroid cancer incidence exists across subgroups, the patterns (i) suggest that changes in diagnostic technology alone do not account for the observed trends and (ii) point to the importance of modifiable behavioral, lifestyle, or environmental factors in understanding this epidemic.
Impact: Given the dramatic and continued increase in thyroid cancer incidence rates, studies addressing the causes of these trends are critical. Cancer Epidemiol Biomarkers Prev; 23(6); 1–13. ©2014 AACR.
